PURINA INSTITUTE WEBINAR:

12.00–12.05pm CST / 18:00–18:05 BST
Introduction,
Liz Devitt, DVM

12.05–12.45pm CST / 18:05–18:45 BST
Diagnosis & Management of Myxomatous Mitral Valve Disease in Dogs,
John D. Bonagura, DVM, DACVIM (Cardiology, Internal Medicine)

• Overview: pathology, incidence/prevalence
• Recognition & diagnosis of MMVD
• Overview: Clinical outcomes
• ACVIM staging system
• Pharmaceutical treatment by ACVIM stage

12.45–1.10pm CST / 18:45–19:10 BST
Nutritional Management in Canine Heart Disease,
Dottie Laflamme, DVM, PhD, DACVN

• Nutritional management goals for patients
• ACVIM nutritional guidelines
• Nutrients important in heart health & disease
• New insights about managing early stage MMVD
  • The Cardiac Protection Blend

1.10–1.25pm CST / 19:10–19:25 BST
Live Q&A

Diagnosis & Management of Myxomatous Mitral Valve Disease in Dogs

• Relate the pathology of myxomatous mitral valve disease to the findings on cardiac auscultation.
• List the potential clinical outcomes of advanced myxomatous mitral and tricuspid valvular disease.
• Indicate the cardiac and pulmonary complications most often associated with the development of ascites in myxomatous valvular disease. 
• Outline basic and advanced hospital treatments of congestive heart failure caused by myxomatous valvular disease.
• Define the stages of myxomatous mitral valve disease as outlined in the ACVIM consensus statement and describe the management approaches to Stages B2, C and D.

Nutritional Management in Canine Heart Disease

• Understand the ACVIM staged nutritional guidelines, and the limitations of them.
• Understand how key nutrients can slow the progression of MMVD in its early stages.
• Understand the role of sodium and other nutrients in advanced heart disease.
• Understand when and how to feed dogs with heart disease and heart failure.